| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 7e-06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |